Mark J. Millan

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

Mark J. Millan, Lisa Maiofiss, Didier Cussac et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 483 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

Robert D. Schreiber, Mauricette Brocco, Valérie Audinot et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 295 citations

Medicine, Neuroscience, Pharmacology +17

Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

Mark J. Millan · Journal of Pharmacology and Experimental Therapeutics · 2000 · 287 citations

Medicine, Pharmacology, Psychiatry +17

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study

Adrian Newman‐Tancredi, Samantha Gavaudan, Caroline Conte et al. · European Journal of Pharmacology · 1998 · 226 citations

Medicine, Pharmacology, Psychiatry +13

Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism

Christoph Stein, Mark J. Millan, Alexander Yassouridis et al. · European Journal of Pharmacology · 1988 · 213 citations

Nursing, Pharmacology, Inflammation +13